News
AbbVie’s 24-hour Parkinson’s therapy to roll out on NHS
Around 1,000 people with Parkinson’s disease will be able to access treatment with AbbVie’s Produodopa, the first therapy that can be delivered by a 24-hour subcutaneous i
